Biotech / MedTech

NeoSci Ventures (NSV), a venture builder and investor with offices in Singapore, Taiwan and the United States, has raised S$70 million ($53 million) for its inaugural institutional venture fund.

OMRON Healthcare has started full-scale production at its first India factory near Chennai, targeting a tenfold capacity increase by 2028.

METiS TechBio and Eli Lilly will develop tissue-targeted RNA delivery systems in a collaboration carrying up to about $1.1 billion in milestones.

Drylab AI, an autonomous agent platform for life sciences research, has raised $3 million in a seed round led by Vertex Ventures Southeast Asia & India, with participation from PatSnap.

TCGX has closed an oversubscribed $600 million fund to invest across stages in Asia-based biotechnology companies and is opening Hong Kong and Shanghai offices.

MetaGO's Kunal Kapoor and Dr. Kaushal Patel discuss clinical oversight, health-data tracking, AI safeguards and long-term outcomes in digital GLP-1 care.

MIMS Group is expanding MIMS Pulse and eMIMS Plus across markets while growing its medical communications and AI-enabled content capabilities.

Alibaba DAMO Academy has published research on EAGLE for esophageal cancer screening and RADAR for broad abdominal CT interpretation. Both remain research systems rather than approved clinical products.

GSK agreed to acquire global rights to a Chimagen multiple myeloma program in a deal with an undisclosed upfront fee and contingent payments totaling up to $750 million.

Australia’s VVMF has secured a TGA manufacturing license for its Westmead facility to produce specified viral vectors under GMP standards.